THE appearance of non-metallic inclusions and their influence on the mechanical and corrosion properties of steel have been the subject of many investigations 1,2. For the determination of ...

Keep Up with the GGSC Happiness Calendar Guard against stress and overwhelm this month While certainly we are all still learning the best ways to co-exist and cooperate, evidence suggests that a ...

Throughout history, humanity has chased the elusive promise of eternal youth. From mythical fountains to today’s anti-aging creams, the pursuit of staying forever young remains constant. But beneath ...

Proficio Capital Partners LLC purchased a new stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC.

α-synuclein Complex I and IV deficiency Huntington's disease Neuronal intra-nuclear and intra-cytoplasmic inclusions Intra-nuclear (neurons) Huntingtin (containing polyglutamine repeat expansion ...

Despite advances in neonatal care, effective treatments for brain injury in premature babies remain a significant unmet need. Researchers at the School of Clinical Sciences at Monash Health and The ...

Intra-Cellular Therapies' Caplyta shows strong sales growth and label expansion potential, making it a valuable acquisition for Johnson & Johnson at $14 billion. JNJ's acquisition of ITCI is ...

“The demonstration that Enterobacter isolates can hide inside macrophages has important clinical implications for the treatment of infected patients since antibiotics cannot reach the intracellular ...

Intra-Cellular Therapies (NASDAQ:ITCI), Inc. has moved one step closer to becoming a wholly owned subsidiary of Johnson & Johnson, following the expiration of the waiting period under the ...